2005
DOI: 10.1016/j.jpba.2005.05.009
|View full text |Cite
|
Sign up to set email alerts
|

The inclusion complexes of hesperetin and its 7-rhamnoglucoside with (2-hydroxypropyl)-β-cyclodextrin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
49
0

Year Published

2009
2009
2022
2022

Publication Types

Select...
4
2
2

Relationship

0
8

Authors

Journals

citations
Cited by 78 publications
(51 citation statements)
references
References 31 publications
2
49
0
Order By: Relevance
“…The inclusion of hesperetin and hesperidin in (2-hydroxypropyl)-b-cyclodextrin (HP-b-CD) [159]; quercetin and myricetin in HP-b-CD, maltosyl-b-CDs, and b-CDs [160]; kaempferol, quercetin, and myricetin in HP-b-CD [161]; 3-hydroxyflavone (3-OHeF), morin, and quercetin in a-and b-CDs [162]; and rutin in b-CD [163] have been studied, and their water solubility improved by encapsulation. In addition, their antioxidant activities were shown to be increased in these CD-encapsulated systems.…”
Section: Inclusion Encapsulation-cyclodextrinsmentioning
confidence: 99%
“…The inclusion of hesperetin and hesperidin in (2-hydroxypropyl)-b-cyclodextrin (HP-b-CD) [159]; quercetin and myricetin in HP-b-CD, maltosyl-b-CDs, and b-CDs [160]; kaempferol, quercetin, and myricetin in HP-b-CD [161]; 3-hydroxyflavone (3-OHeF), morin, and quercetin in a-and b-CDs [162]; and rutin in b-CD [163] have been studied, and their water solubility improved by encapsulation. In addition, their antioxidant activities were shown to be increased in these CD-encapsulated systems.…”
Section: Inclusion Encapsulation-cyclodextrinsmentioning
confidence: 99%
“…There have been a number of recent reviews focusing on the encapsulation of the more widely used polyphenols, discussing their effectiveness, variations, developments and trends (Barras et al, 2009;Das, Ng, 2010;Di Mattia et al, 2009;Dube et al, 2010;Ersus, Yurdagel, 2007;Fang et al, 2006;Hu et al, 2008;Kosaraju, Dath, Lawrence, 2006;Laine et al, 2008;Liang et al, 2011;Lucas-Abellan et al, 2007;Mourtzinos et al, 2007;Shi et al, 2007;Shutava et al, 2009;Tommasini et al, 2005;Zhang, Mou, Du, 2007;Xiong et al, 2006;Yu, Huang, 2010).…”
Section: Introductionmentioning
confidence: 99%
“…We used an ex vivo human skin model to investigate the protective activity of the flavonoid hesperetin against BaP-induced toxicity. This study was aimed to evaluate the biological activity of the hesperetin complex obtained by inclusion complex formation with β-cyclodextrin, which increased its antioxidant properties (Tommasini et al 2005). Data obtained have demonstrated as a short time treatment of human skin tissue with HE/HP-β-CyD complex significantly reduces oxidative stress conditions resulting by BaP exposure.…”
Section: Discussionmentioning
confidence: 99%
“…Inclusion complex with 1:1 HE/HP-β-CyD molar ratio was prepared by co-evaporation method (Tommasini et al 2005) by shaking the appropriate amounts of drug and macrocycle in water. Briefly, the mixture was stirred for 1 h, under controlled temperature (25.0± 0.01°C).…”
Section: Preparation Of An Inclusion Complex Of Hesperetinmentioning
confidence: 99%